<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Met55Val polymorphism in the small ubiquitin-like modifier 4 (SUMO4) gene has been associated with susceptibility not only to type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, but also to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We tried to confirm the association with susceptibility to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and to investigate its role in <z:e sem="disease" ids="C0011875" disease_type="Disease or Syndrome" abbrv="">diabetic vascular complications</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The polymorphism was genotyped in two independent Japanese samples (Wakayama and Tokyo) by the TaqMan method </plain></SENT>
<SENT sid="3" pm="."><plain>Susceptibility to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and prevalence of <z:e sem="disease" ids="C0011875" disease_type="Disease or Syndrome" abbrv="">diabetic vascular complications</z:e> (<z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, and <z:hpo ids='HP_0000112'>nephropathy</z:hpo>) were evaluated by case-control study and multivariate logistic regression analysis, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>There were no significant differences in the frequency of alleles or genotypes between patients and controls </plain></SENT>
<SENT sid="5" pm="."><plain>The Val allele, however, was associated with higher prevalence of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> in patients in both groups (Wakayama, n=423, odds ratio, 1.64; 95% confidence interval, 1.02-2.64; P=0.041; Tokyo, n=451, odds ratio, 1.58; 95% CI, 1.07-2.34; P=0.021, in an additive model, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>No significant associations were observed with other <z:e sem="disease" ids="C0011875" disease_type="Disease or Syndrome" abbrv="">diabetic vascular complications</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Although association of the polymorphism with susceptibility to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:hpo ids='HP_0000112'>nephropathy</z:hpo> was not replicated, an association of the polymorphism with risk of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is suggested </plain></SENT>
</text></document>